An observational study in Hernia Recurrence Post Laparoscopic Incisional Hernia Repair in Liver Transplant Versus Non-transplant Patients., sponsored by Medical University Innsbruck. Completed at 1 site in Austria. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-04-25.
Sponsored by Medical University Innsbruck · Observational
Retrospective analysis of patients undergoing laparoscopic incisional hernia repair.
Study group: Patients with incisional hernia post liver transplantation Control group: Patients with incisional hernia post any other laparotomy in the upper quadrant.
Primary study outcome parameter: Risk of hernia recurrence. Secondary study outcome parameters: - Hernia repair-related infection rate
4,279 studies on the registry are indexed under Recurrence; 988 are open to participants now.
This study's enrollment of 112 is below the median of 200 across 702 observational studies indexed under Recurrence.
Browse Recurrence studies →Medical University Innsbruck is the lead sponsor of 182 studies on the registry; 49 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient with incisional hernia post liver transplantation
Exclusion Criteria:
Patients after liver transplantation
Other: Surgery
Patients with an abdominal incisional hernia without a history of immunosuppresion
Other: Surgery
Hernia recurrence post laparoscopic incisional hernia repair
Time frame: 1 - 74 months post surgery
This study is completed, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University Innsbruck